TY - JOUR
T1 - Platelet-derived growth factor-AA promotes placental choriocarcinoma JAR cell proliferation via primary cilia
AU - Sheu, Shi Yuan
AU - Wang, Chia Yih
AU - Cheng, Hui ling
AU - Tsai, Pei Yin
N1 - Funding Information:
4. We are grateful for the support from the Core Research Laboratory, College of Medicine, National Cheng Kung University .
Funding Information:
3. This study was supported by grant from Ministry of Science and Technology , MOST106-2320-B-006-056-MY3 and MOST109-2320-B-006-042 -MY3 to Chia-Yih Wang.
Funding Information:
1. This study was supported by grant from Chung Shan Medical University Hospital ( CSH-2019-A-009 ) to Shi-Yuan Sheu.
Funding Information:
2. This study was supported by grand from the National Cheng Kung University Hospital , NCKUH-10902059 to Pei-Yin Tsai.
Publisher Copyright:
© 2022
PY - 2022/3
Y1 - 2022/3
N2 - Objective: During early pregnancy, the proliferation placental cells is crucial for proper implantation and formation of maternal–fetal circulation. Platelet-derived growth factor-AA (PDGF-AA) has been detected in placenta during early pregnancy; however, the role of PDGF-AA in placental cell growth has not been studied extensively. Primary cilium, a centrosome-based cellular protrusion, is an signaling hub for regulating development and differentiation. Importantly, the receptor of PDGF-AA (Pdgfr-α) is detected in the primary cilium and primary cilia-mediated PDGF-AA signaling regulates development and differentiation. Here we would like to investigate whether PDGF-AA regulates placental cell growth and whether primary cilia play roles in this process. Materials and methods: Human placental choriocarcinoma JAR cells were treated with PDGF-AA followed by examining cell growth. Primary cilia and subcellular localization of Pdgfr-α were observed by immunofluorescence staining. Manipulation of primary cilia was performed by treating cells with roscovitine or by transfecting cells with siRNA against IFT88. Results: Here we showed that PDGF-AA induced JAR cell proliferation. In addition, JAR cells grew primary cilia where Pdgfr-α was detected. More importantly, pharmacological inhibition of primary cilia formation or depletion of cilia-related gene, IFT88, alleviated PDGF-AA induced JAR cell proliferation. Conclusion: Thus, our study show that PDGF-AA facilitates human placental choriocarcinomaJARcell growth via primary cilia.
AB - Objective: During early pregnancy, the proliferation placental cells is crucial for proper implantation and formation of maternal–fetal circulation. Platelet-derived growth factor-AA (PDGF-AA) has been detected in placenta during early pregnancy; however, the role of PDGF-AA in placental cell growth has not been studied extensively. Primary cilium, a centrosome-based cellular protrusion, is an signaling hub for regulating development and differentiation. Importantly, the receptor of PDGF-AA (Pdgfr-α) is detected in the primary cilium and primary cilia-mediated PDGF-AA signaling regulates development and differentiation. Here we would like to investigate whether PDGF-AA regulates placental cell growth and whether primary cilia play roles in this process. Materials and methods: Human placental choriocarcinoma JAR cells were treated with PDGF-AA followed by examining cell growth. Primary cilia and subcellular localization of Pdgfr-α were observed by immunofluorescence staining. Manipulation of primary cilia was performed by treating cells with roscovitine or by transfecting cells with siRNA against IFT88. Results: Here we showed that PDGF-AA induced JAR cell proliferation. In addition, JAR cells grew primary cilia where Pdgfr-α was detected. More importantly, pharmacological inhibition of primary cilia formation or depletion of cilia-related gene, IFT88, alleviated PDGF-AA induced JAR cell proliferation. Conclusion: Thus, our study show that PDGF-AA facilitates human placental choriocarcinomaJARcell growth via primary cilia.
UR - http://www.scopus.com/inward/record.url?scp=85125119110&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85125119110&partnerID=8YFLogxK
U2 - 10.1016/j.tjog.2022.02.018
DO - 10.1016/j.tjog.2022.02.018
M3 - Article
C2 - 35361391
AN - SCOPUS:85125119110
SN - 1028-4559
VL - 61
SP - 299
EP - 305
JO - Taiwanese Journal of Obstetrics and Gynecology
JF - Taiwanese Journal of Obstetrics and Gynecology
IS - 2
ER -